Myopia progression control
LAMP assigned 438 children to three atropine concentrations or placebo. The effect was dose dependent, with 0.05% atropine producing the smallest refractive and axial-length changes at one year.
doi: 10.1016/j.ophtha.2018.05.029A US randomised trial in 187 children did not confirm the expected advantage of 0.01% atropine over placebo. The result cautions against assuming equal efficacy across doses and populations.
doi: 10.1001/jamaophthalmol.2023.2855A small study compared orthokeratology alone with the addition of repeated low-level red-light therapy.
doi: 10.1080/09286586.2025.2580682A pilot trial compared repeated low-level red light with single-vision spectacles in schoolchildren.
doi: 10.1080/09286586.2025.2500020The study compared aspheric orthokeratology lenses with different back optic-zone diameters.
doi: 10.1016/j.clae.2025.102491A systematic review collected costs of correction, monitoring, complications and myopia-control interventions.
doi: 10.7189/jogh.15.04322